Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The funds will be used to boost customer outreach, secure IP rights, scale infrastructure, and grow the core team and to revolutionise healthcare through gut microbiome science
Iom Bioworks, a deep science company pioneering microbiome-focused healthcare, has secured $4 Cr seed round funding led by InflexionPoint Ventures (IPV). The capital will be leveraged for marketing, securing intellectual property claims, strengthening core infrastructure and scaling scientific and commercial teams.
“Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, immunity, metabolism, and even mood. Understanding it can help prevent a myriad of these diseases and also provide a better quality of life. Iom Bioworks is making this cutting-edge science accessible, personalised and importantly, actionable. With their vision and science, they make a compelling bet in preventive and therapeutic healthcare”, says Vinay Bansal, Founder, IPV.
“Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome. By empowering our inner ecosystem through prebiotics and food and lifestyle centred around the bacteria, we aim to energise daily life while preserving the joy of living. Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision”, says Bipin Pradeep Kumar, Co-Founder and CEO, Iom Bioworks.